|
Market Closed -
Börse Stuttgart
15:56:13 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 96.65 EUR | +20.51% |
|
-0.19% | +8.89% |
| 08-19 | Moderna, Merck breakthrough could usher in wave of cancer vaccines | RE |
| 08-19 | US stock futures steady after tech slump; investors focus on Middle East tensions | RE |
Company Valuation: BioNTech SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 54,749 | 34,159 | 22,698 | 26,387 | 19,497 | 24,375 | - | - |
| Change | - | -37.61% | -33.55% | 16.25% | -26.11% | 25.02% | - | - |
| Enterprise Value (EV) 1 | 53,358 | 20,496 | 11,253 | 16,879 | 12,356 | 13,007 | 14,345 | 14,936 |
| Change | - | -61.59% | -45.1% | 50% | -26.8% | 5.27% | 10.28% | 4.12% |
| P/E | 5.72x | 3.72x | 24.9x | -39.7x | -17.3x | -17.6x | -18.7x | -25.1x |
| PBR | 4.62x | 1.7x | 1.12x | - | 1.06x | 1.38x | 1.49x | 1.61x |
| PEG | - | -0.79x | -0.3x | 0x | -0.2x | -1x | 3.11x | 1x |
| Capitalization / Revenue | 2.89x | 1.97x | 5.94x | 9.59x | 6.79x | 13.5x | 13.2x | 10.6x |
| EV / Revenue | 2.81x | 1.18x | 2.95x | 6.14x | 4.31x | 7.2x | 7.78x | 6.5x |
| EV / EBITDA | 3.47x | 1.61x | 12.9x | -16.6x | -12.1x | -9.35x | -9.84x | -13.9x |
| EV / EBIT | 3.49x | 1.62x | 16.3x | -12.8x | -8.79x | -7.22x | -8.56x | -12.2x |
| EV / FCF | 72.5x | 1.55x | 2.41x | -69x | 44x | -7.45x | -7.38x | -8.73x |
| FCF Yield | 1.38% | 64.5% | 41.5% | -1.45% | 2.27% | -13.4% | -13.6% | -11.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 39.63 | 37.77 | 3.83 | -2.77 | -4.7 | -5.523 | -5.19 | -3.869 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,977 | 17,311 | 3,819 | 2,751 | 2,870 | 1,807 | 1,843 | 2,297 |
| EBITDA 1 | 15,359 | 12,766 | 873.8 | -1,016 | -1,022 | -1,392 | -1,458 | -1,076 |
| EBIT 1 | 15,284 | 12,643 | 690.4 | -1,314 | -1,405 | -1,800 | -1,676 | -1,220 |
| Net income 1 | 10,292 | 9,434 | 930.3 | -665.3 | -1,136 | -1,348 | -1,313 | -953 |
| Net Debt 1 | -1,391 | -13,663 | -11,445 | -9,508 | -7,141 | -11,369 | -10,031 | -9,439 |
| Reference price 2 | 226.68 | 140.56 | 95.48 | 110.06 | 81.08 | 97.03 | 97.03 | 97.03 |
| Nbr of stocks (in thousands) | 241,521 | 243,019 | 237,716 | 239,740 | 240,455 | 251,204 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 3/20/24 | 3/10/25 | 3/10/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.02x | 7.72x | 15.73x | 1.34% | 73.45B | |
| 36.15x | 9.26x | 28.49x | 0.04% | 62.99B | |
| -81.2x | 15.18x | -77.46x | -.--% | 28.05B | |
| 32.25x | 6.34x | 16.79x | -.--% | 25.42B | |
| -14.35x | 5.17x | -6.66x | -.--% | 23.3B | |
| 26.57x | 5.01x | 16.8x | -.--% | 19.45B | |
| 52.91x | 19.58x | 39.65x | 0.29% | 18.16B | |
| -7088.72x | 40.96x | -262.55x | -.--% | 16.53B | |
| 16.43x | 4.87x | 11.36x | -.--% | 13.16B | |
| Average | -777.55x | 12.68x | -24.21x | 0.19% | 31.17B | |
| Weighted average by Cap. | -404.19x | 10.88x | -7.47x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BNTX Stock
- 22UA Stock
- Valuation BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
